Background: Amyotrophic Lateral Sclerosis (ALS), an incurable motor neuron disease, primarily affects those between the ages of 60-79, and sees an approximate post-diagnosis life-expectancy of only 2-5 years. The condition has an unpredictable but ultimately terminal trajectory that poses a number of challenges for patients, caregivers and healthcare providers. One of these major challenges is the need to make sure that patients’ quality-of-life is as high as possible throughout the disease course. Many factors have been shown to influence quality-of-life, including patients and caregivers’ ability to cope and adapt to the changes associated with the disease. There is some evidence to suggest that the manner in which healthcare providers pr...
Background: Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that drama...
Objective The aim of this study was to explore the support needs of Dutch informal caregivers of pat...
Background: There is little known about how people live or manage coping with motor neurone disease ...
Background: The absence of curative medication for amyotrophic lateral sclerosis (ALS) makes palliat...
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, is a progressive neurodegenerative dis...
ObjectivesThe aim of this study is to collect the perspectives and values of people affected by amyo...
Background: Amyotrophic lateral sclerosis (ALS) is a degenerative motor neuron disease leading to pr...
The overall aim of this thesis was to investigate quality of life, coping and emotional distress (i....
Living with amyotrophic lateral sclerosis (ALS) is a complex and difficult experience that necessita...
ALS is a neurodegenerative disease without curative treatment. The knowledge of the relationship bet...
Amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) is a systemic and fatal neurodegenera...
Amyotrophic lateral sclerosis (ALS) is a chronic, progressive, disabling and incurable disease. It e...
Amyotrophic Lateral Sclerosis (ALS) is the most common progressive and fatal neurodegenerative disea...
This study explored the illness experience of people with amyotrophic lateral sclerosis (ALS) to wid...
People with amyotrophic lateral sclerosis (ALS) suffer from a rare, progressive, untreatable, and fa...
Background: Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that drama...
Objective The aim of this study was to explore the support needs of Dutch informal caregivers of pat...
Background: There is little known about how people live or manage coping with motor neurone disease ...
Background: The absence of curative medication for amyotrophic lateral sclerosis (ALS) makes palliat...
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, is a progressive neurodegenerative dis...
ObjectivesThe aim of this study is to collect the perspectives and values of people affected by amyo...
Background: Amyotrophic lateral sclerosis (ALS) is a degenerative motor neuron disease leading to pr...
The overall aim of this thesis was to investigate quality of life, coping and emotional distress (i....
Living with amyotrophic lateral sclerosis (ALS) is a complex and difficult experience that necessita...
ALS is a neurodegenerative disease without curative treatment. The knowledge of the relationship bet...
Amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) is a systemic and fatal neurodegenera...
Amyotrophic lateral sclerosis (ALS) is a chronic, progressive, disabling and incurable disease. It e...
Amyotrophic Lateral Sclerosis (ALS) is the most common progressive and fatal neurodegenerative disea...
This study explored the illness experience of people with amyotrophic lateral sclerosis (ALS) to wid...
People with amyotrophic lateral sclerosis (ALS) suffer from a rare, progressive, untreatable, and fa...
Background: Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that drama...
Objective The aim of this study was to explore the support needs of Dutch informal caregivers of pat...
Background: There is little known about how people live or manage coping with motor neurone disease ...